Egypt - Opella has become the first global consumer healthcare company to achieve B Corp Certification after meeting the social and environmental standards set by B Lab, the non-profit organisation ...

Opella has become the first global consumer healthcare company to achieve B Corp Certification after meeting the social and environmental standards s ...

Egypt – Opella is the first global consumer healthcare company to achieve B Corp Certification, after meeting the rigorous social and environmental standards set by B Lab, the nonprofit behind the ...

NEW YORK – Adagene said on Tuesday that Sanofi has made a $25 million investment in the company to support a clinical trial of the anti-CTLA-4 agent muzastotug and exercised its option under their ...

This achievement marks a milestone on Opella’s journey to deliver responsible self-care for people and the planet. This certification follows an intensive four-year transformation effort, during which ...

--Sanofi today announced it has awarded over $1 million in grants through its inaugural Healthy Futures Solution Fund to support local nonprofits across Massachusetts that are advancing community ...

(RTTNews) - The U.S. Food and Drug Administration has granted orphan drug designation to riliprubart for the investigational treatment of antibody-mediated rejection (AMR) in solid organ ...